TRAVERSA SERGIO 4
4 · RELMADA THERAPEUTICS, INC. · Filed Jun 30, 2025
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-26+800,000→ 800,000 totalExercise: $0.67From: 2025-09-26Exp: 2035-06-26→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The options vest in 16 equal quarterly installments commencing on September 26, 2025.